LivaNova
LIVN
#3670
Rank
C$4.86 B
Marketcap
C$89.16
Share price
0.96%
Change (1 day)
23.76%
Change (1 year)
Categories

P/E ratio for LivaNova (LIVN)

P/E ratio as of December 2025 (TTM): -16.0

According to LivaNova's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.015. At the end of 2024 the company had a P/E ratio of 39.9.

P/E ratio history for LivaNova from 2015 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202439.9-75.31%
2023162-568.7%
2022-34.57.32%
2021-32.1243.72%
2020-9.35-60.2%
2019-23.50.45%
2018-23.4-84.78%
2017-154340.88%
2016-34.9

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Inari Medical
NARI
-66.1 312.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
41.8-361.23%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.